Tegopen en es it fr

Tegopen Brand names, Tegopen Analogs

Tegopen Brand Names Mixture

  • No information avaliable

Tegopen Chemical_Formula


Tegopen RX_link


Tegopen fda sheet

Tegopen FDA

Tegopen msds (material safety sheet)

Tegopen MSDS

Tegopen Synthesis Reference

No information avaliable

Tegopen Molecular Weight

924.079 g/mol

Tegopen Melting Point

170.0 oC

Tegopen H2O Solubility

750 mg/L

Tegopen State


Tegopen LogP


Tegopen Dosage Forms

Slow intravenous-infusion

Tegopen Indication

Used to treat potentially life threatening fungal infections.

Tegopen Pharmacology

Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, Rhodotorula, Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo, and Aspergillus fumigatus are all inhibited by concentrations of amphotericin B ranging from 0.03 to 1.0 mcg/mL in vitro. While Candida albicans is generally quite susceptible to amphotericin B, non-albicans species may be less susceptible. Pseudallescheria boydii and Fusarium sp. are often resistant to amphotericin B. The antibiotic is without effect on bacteria, rickettsiae, and viruses.

Tegopen Absorption

Bioavailability is 100% for intravenous infusion.

Tegopen side effects and Toxicity

Oral, rat: LD50 = >5 gm/kg. Amphotericin B overdoses can result in cardio-respiratory arrest.

Tegopen Patient Information

No information avaliable

Tegopen Organisms Affected

Various Fungus Species